Search results for: “Crispr”
-
Crispr Licensed for Eye Disease Gene Therapies
A developer of inherited eye disease therapies is acquiring rights to the gene editing technology Crispr for treatments that work inside the eyes.
-
Trial Underway for Crispr Lymphoma Therapy
A clinical trial enrolled its first participant testing the safety of a treatment for lymphoma, a type of cancer, using the gene-editing technique Crispr.
-
Trial Shows In-Body Crispr Therapy Feasibility
Early clinical trial data show gene editing with Crispr performed inside the body can correct an inherited neurological condition, with few adverse effects.
-
Biotechs Partner on Crispr Therapies for Neuro Disorders
Two biotechnology companies are designing therapies to deliver edited genes to treat Friedreich’s ataxia and amyotrophic lateral sclerosis, or ALS.
-
Crispr Treatment Leads to Durable Cholesterol Reduction
A developer of gene editing for inherited heart disease reports lab monkeys given its therapy experience lower cholesterol levels for at least eight months.
-
Graphene Crispr Chip Detects Small Genetic Differences
An academic-industry team designed a computer chip with graphene circuits using the gene-editing technique Crispr to detect fine genetic differences in samples.
-
Trial to Test Direct Crispr Blood Stem Cell Edits
A clinical trial is set to begin that tests a direct form of gene editing with Crispr to correct inherited malfunctioning genes causing sickle cell disease.
-
Crispr Enables Inhaled Flu, Covid-19 Treatment
A biomedical engineering lab designed and tested in lab animals gene-edited therapies for influenza and Covid-19, inhaled by patients with a home device.
-
Crispr-Edited Bananas Get Industry Funding
A popular type of banana, genetically edited to resist a soil fungus that threatens this fruit worldwide, is now backed by a major American food brand.
-
AbbVie Licenses Engineered Crispr Cell Process
Drug maker AbbVie is acquiring a technology using the gene-editing process Crispr to produce new off-the-shelf engineered T-cells as disease therapies.